Abstract
Mutations in sequences at the C terminus of the capsid precursor protein of human immunodeficiency virus type 1 that affect the viral p6 protein prevent release of budded virus particles from the cell surface. The experiments reported here define an important step in the life cycle of the virus, the release of the budded particle from a tether that binds the assembled particle to the cell surface. Inhibition of the release of the viral capsid proteins by interferon alpha indicates that this step of virus maturation may be sensitive to inhibition by antiviral drugs.
MeSH Terms
Animals
Base Sequence
Capsid/genetics
Cell Membrane/ultrastructure
Cells, Cultured
Chlorocebus aethiops
DNA Mutational Analysis
Gene Products, gag/genetics
HIV-1/genetics,growth & development,metabolism
Human Immunodeficiency Virus Proteins
Interferon Type I/pharmacology
Molecular Sequence Data
Oligonucleotides/chemistry
Protein Precursors/metabolism
Viral Regulatory and Accessory Proteins/physiology
Virus Replication
Chemicals
Gene Products, gag
Human Immunodeficiency Virus Proteins
Interferon Type I
Oligonucleotides
Protein Precursors
Viral Regulatory and Accessory Proteins
vpu protein, Human immunodeficiency virus 1
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Göttlinger H G
Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, MA 02115.
Dorfman T
Sodroski J G
Haseltine W A
References (25)
25 references, click to expand
-
Use of eukaryotic expression technology in the functional analysis of cloned genes.
Methods Enzymol. 1987;152:684-704
PMID: 3657593
-
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
Virology. 1987 Jan;156(1):171-6
PMID: 3643678
-
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Methods Enzymol. 1987;154:367-82
PMID: 3323813
-
Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15.
AIDS Res Hum Retroviruses. 1987 Fall;3(3):253-64
PMID: 3481270
-
Active human immunodeficiency virus protease is required for viral infectivity.
Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90
PMID: 3290901
-
The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.
J Virol. 1988 Nov;62(11):3993-4002
PMID: 3262776
-
HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems.
Cell. 1988 Dec 23;55(6):1159-69
PMID: 3060262
-
Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus.
J Acquir Immune Defic Syndr. 1988;1(5):441-52
PMID: 2851651
-
Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
Science. 1989 May 5;244(4904):575-7
PMID: 2470148
-
Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.
J Virol. 1989 Jun;63(6):2550-6
PMID: 2657099
-
Functional role of human immunodeficiency virus type 1 vpu.
Proc Natl Acad Sci U S A. 1989 Jul;86(13):5163-7
PMID: 2472639
-
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.
Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781-5
PMID: 2788277
-
Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.
Cell. 1989 Oct 6;59(1):103-12
PMID: 2676191
-
The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release.
J Virol. 1990 Feb;64(2):621-9
PMID: 2404139
-
Myristoylation-dependent replication and assembly of human immunodeficiency virus 1.
Proc Natl Acad Sci U S A. 1990 Jan;87(2):523-7
PMID: 2405382
-
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.
J Virol. 1990 May;64(5):1920-6
PMID: 2109098
-
Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein.
J Virol. 1991 Feb;65(2):922-30
PMID: 1987379
-
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).
Science. 1983 May 20;220(4599):868-71
PMID: 6189183
-
Immunoglobulin gene transcription is activated by downstream sequence elements.
Cell. 1983 Jul;33(3):741-8
PMID: 6409419
-
Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.
Science. 1984 May 4;224(4648):503-5
PMID: 6200937
-
HTLV-III gag protein is processed in yeast cells by the virus pol-protease.
Science. 1986 Mar 28;231(4745):1580-4
PMID: 2420008
-
A molecular clone of HTLV-III with biological activity.
Nature. 1985 Jul 18-24;316(6025):262-5
PMID: 2410792
-
Complete nucleotide sequence of the AIDS virus, HTLV-III.
Nature. 1985 Jan 24-30;313(6000):277-84
PMID: 2578615
-
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.
Cell. 1986 Mar 28;44(6):941-7
PMID: 2420471
-
Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24.
J Virol. 1988 Mar;62(3):795-801
PMID: 3123712